(Food-Beverage-News.Com, September 08, 2021 ) The global biosurfactants market is estimated at USD 4.20 billion in 2017 and is projected to reach USD 5.52 billion by 2022, at a CAGR of 5.6% from 2017 to 2022. Increasing demand for green solutions is the major factor driving the growth of the biosurfactants market. The growth in the market is also triggered by the awareness created by regulatory bodies towards the adoption of biologically derived surfactants. Contracts & agreements is the key growth strategy adopted by the leading market players, between 2015 and 2017. Major players have also adopted the new product launches strategy to strengthen their positions in the global biosurfactants market.
Key players operating in the global biosurfactants market include Evonik (Germany), Jeneil Biotech (US), Ecover (Belgium), Soliance (France), AGAE Technologies (US), Saraya (Japan), and Biotensidon (Germany).
Evonik is a key player in the global biosurfactants market. The company offers a comprehensive range of biosurfactants for various end-use applications, such as detergents, industrial cleaning, cosmetics, food processing, oilfield chemicals, biochemicals, and medical. Evonik is the first company to commercialize sophorolipid biosurfactants on an industrial scale, as a part of its strategic developmental activity. This enabled Evonik to further enhance its R&D activities and focus on tapping into other possible applications of sophorolipids.
Logos Technologies (US) is another leading manufacturer in the biosurfactants market. The company adopted contracts & agreements as a key growth strategy to expand its business globally. It has been focusing on developing biosurfactants through innovations in products. The company offers products based on the rhamnolipid line of biosurfactants for household cleaners, personal care, agriculture, bioremediation, enhanced oil recovery, medical, and wastewater treatment. In October 2016, Logos announced a partnership with Ohio Soybean Council, US to further develop its NatSurFact biosurfactant production process. The joint venture is expected to help Logos commercialize its biosurfactant in the market.